Read + Share
Amedeo Smart
Independent Medical Education
Baumann A, Burger K, Brandt A, Staltner R, et al. GW9662, a peroxisome proliferator-activated receptor gamma antagonist, attenuates the development of non-alcoholic fatty liver disease. Metabolism 2022;133:155233.PMID: 35654114
Email
LinkedIn
Facebook
Twitter
Privacy Policy